Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tom J Parry

Showing results (1-10 of 28) with videos related to

Pageof 3
Sort By:
Journal of Drug Assessment|August 19, 2016
Effects of dalfampridine and its metabolites on cloned human potassium channels Kv 1.1, Kv 1.2, and Kv 1.4 expressed in human embryonic kidney cellsAnthony Caggiano, Andrew Blight, Tom J Parry
Journal of Drug Assessment|August 19, 2016
Identification of metabolites of dalfampridine (4-aminopyridine) in dog and ratAnthony Caggiano, Andrew Blight, Tom J Parry
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 31, 2023
Neurosteroid Receptor Modulators for Treating Traumatic Brain InjuryTodd A Verdoorn, Tom J Parry, Graziano Pinna, et al.
European Journal of Pharmacology|February 2, 2006
Effects of drug combinations on smooth muscle cell proliferation: an isobolographic analysisTom J Parry, Rathna Thyagarajan, Dennis Argentieri, et al.
European Journal of Pharmacology|November 8, 2005
Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteriesTom J Parry, Ruth Brosius, Rathna Thyagarajan, et al.
Neurorehabilitation and Neural Repair|January 22, 2017
Clinically Relevant Levels of 4-Aminopyridine Strengthen Physiological Responses in Intact Motor Circuits in Rats, Especially After Pyramidal Tract InjuryAnil Sindhurakar, Asht M Mishra, Disha Gupta, et al.
Journal of Neuroscience Research|December 15, 2015
An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in ratsJennifer F Iaci, Tom J Parry, Zhihong Huang, et al.
Brain Research|May 19, 2018
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelinationCharlene Cui, Jing Wang, Ariana P Mullin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosisTom J Parry, Zhihong Huang, Cailin Chen, et al.
Journal of Neuroscience Methods|December 17, 2016
Recovery of sensorimotor function following sciatic nerve injury across multiple rat strainsAnindita Ganguly, Corissa McEwen, Erika L Troy, et al.
Pageof 3

Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Journal of Drug Assessment|August 19, 2016
Effects of dalfampridine and its metabolites on cloned human potassium channels Kv 1.1, Kv 1.2, and Kv 1.4 expressed in human embryonic kidney cellsAnthony Caggiano, Andrew Blight, Tom J Parry
Journal of Drug Assessment|August 19, 2016
Identification of metabolites of dalfampridine (4-aminopyridine) in dog and ratAnthony Caggiano, Andrew Blight, Tom J Parry
Neurotherapeutics : the Journal of the American Society for Experimental Neurotherapeutics|August 31, 2023
Neurosteroid Receptor Modulators for Treating Traumatic Brain InjuryTodd A Verdoorn, Tom J Parry, Graziano Pinna, et al.
European Journal of Pharmacology|February 2, 2006
Effects of drug combinations on smooth muscle cell proliferation: an isobolographic analysisTom J Parry, Rathna Thyagarajan, Dennis Argentieri, et al.
European Journal of Pharmacology|November 8, 2005
Drug-eluting stents: sirolimus and paclitaxel differentially affect cultured cells and injured arteriesTom J Parry, Ruth Brosius, Rathna Thyagarajan, et al.
Neurorehabilitation and Neural Repair|January 22, 2017
Clinically Relevant Levels of 4-Aminopyridine Strengthen Physiological Responses in Intact Motor Circuits in Rats, Especially After Pyramidal Tract InjuryAnil Sindhurakar, Asht M Mishra, Disha Gupta, et al.
Journal of Neuroscience Research|December 15, 2015
An optimized dosing regimen of cimaglermin (neuregulin 1β3, glial growth factor 2) enhances molecular markers of neuroplasticity and functional recovery after permanent ischemic stroke in ratsJennifer F Iaci, Tom J Parry, Zhihong Huang, et al.
Brain Research|May 19, 2018
The antibody rHIgM22 facilitates hippocampal remyelination and ameliorates memory deficits in the cuprizone mouse model of demyelinationCharlene Cui, Jing Wang, Ariana P Mullin, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 12, 2011
Arterial antithrombotic activity of rivaroxaban, an orally active factor Xa inhibitor, in a rat electrolytic carotid artery injury model of thrombosisTom J Parry, Zhihong Huang, Cailin Chen, et al.
Journal of Neuroscience Methods|December 17, 2016
Recovery of sensorimotor function following sciatic nerve injury across multiple rat strainsAnindita Ganguly, Corissa McEwen, Erika L Troy, et al.
Pageof 3